WallStreetZenWallStreetZen

NASDAQ: CME
Cme Group Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cme Group earnings were $3.7B for the trailing 12 months ending Jun 30, 2025, with 14% growth year over year. The latest CME earnings report on Jun 30, 2025 announced Q2 2025 earnings of $1.0B, up 7.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CME reported annual earnings of $3.5B, with 9.3% growth. The next CME earnings date is Oct 22, 2025.

CME past earnings growth

How has CME's earnings growth performed historically?

Company
13.99%
Industry
29.89%
Market
30.19%
CME's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CME's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CME's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CME earnings history

Current Revenue
$6.4B
Current Earnings
$3.7B
Current Profit Margin
57.7%
CME's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

CME Return on Equity

Current Company
13.6%
Current Industry
11.4%
Current Market
26.6%
CME's Return on Equity (13.6%)... subscribe to Premium to read more.
High Return on Equity Performance

CME undefined

Current Company
2.4%
Current Industry
7%
CME is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CME announces earnings.

CME undefined

Current Company
13.39%
Current Industry
16.6%
CME has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CME vs Financial Datum & Stock Exchange Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CME$5.30B$3.72B+9.25%$10.35
MCO$3.49B$2.13B+5.07%$11.82
ICE$6.35B$3.00B+6.14%$5.24
COIN$3.68B$2.86B-2.94%$11.35
NDAQ$2.84B$1.51B+10.27%$2.63
View Top Financial Datum & Stock Exchange Stocks

CME earnings dates

Next earnings date
Oct 22, 2025

Cme Group Earnings Reports & History FAQ

What were Cme Group's earnings last quarter?

On CME's earnings call on Invalid Date, Cme Group (NASDAQ: CME) reported Q2 2025 earnings per share (EPS) of $2.81, up 15.64% year over year. Total CME earnings for the quarter were $1.01 billion. In the same quarter last year, Cme Group's earnings per share (EPS) was $2.43.

If you're new to stock investing, here's how to buy Cme Group stock.

When does Cme Group report earnings?

The next CME earnings date is Invalid Date. Add CME to your watchlist to be reminded of Cme Group's next earnings date.

Is Cme Group profitable or losing money?

As of the last Cme Group earnings report, Cme Group is currently profitable. Cme Group's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $3.72 billion, a 14.1% increase year over year.

What was CME's earnings growth in the past year?

As of Cme Group's earnings date in Invalid Date, Cme Group's earnings has grown 13.99% year over year. This is 15.9 percentage points lower than the US Financial Data & Stock Exchanges industry earnings growth rate of 29.89%. CME earnings in the past year totalled $3.72 billion.

What are Cme Group's earnings expectations?

The current EPS estimate for Cme Group's earnings report in Invalid Date is $2.71.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.